Champions Oncology (CSBR) Misses Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.90 +1.87%
Financial Fact:
Personalized oncology solutions: 511K
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Personalized oncology solutions: 511K
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of $0.04, $0.04 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $16.6 million versus the consensus estimate of $16.43 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arch Capital (ACGL) PT Raised to $106 at Keefe, Bruyette & Woods
- Adient (ADNT) 4300 contracts of November 17.50 calls trade
- Freedom Broker Downgrades Marriott International (MAR) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
